Columbia University

Other

Yuan Chang

Patrick S Moore

James J Russo

Isidore S Edelman

Roy A Bohenzky

Thomas Friedrich Schulz

Guy R Simpson

A bow sight light mounting kit for illuminating an archery bow includes a bow sight light control unit that includes a power source, a motion sensor, and a customizable timer; a LED light, the LED light adapted for being attached to the bow sight light control unit; and a first mounting plate, the first mounting plate attaching the bow sigh light control unit to the archery bow. The motion sensor detects a movement of the archery bow and sends a signal to the customizable timer; the customizable timer turns on the LED light after receiving the signal and keeps the LED light on for a pre-set time period; and the customizable timer turns off the LED light after the pre-set time period.

Motion activated bow sight light

The present invention provides a method using a non contact Z height laser scan sensor to measure/detect an object surface containing extruded shapes with different Z axis elevation heights to determine the position where to precisely inkjet print outline contours, legends, logo images, or solid fill with materials. The apparatus consist of a printing carriage, a supporting beam, a printing platen for the object to be placed and a control system. The said printing carriage is installed with print heads and a laser Z height scan sensor. The object with uneven Z height surface elevation features to be printed is placed on the printing platen. The said printing carriage with the laser Z height scan sensor will scan across the object on the X and Y axis to detect the exact target positions of the uneven Z height surface elevation contours on the object. The image processing program can then calculate a precise position to print a given image, or compute an image from the contour shapes to be printed on the object. The method can be featured with high degree of automation, easy control and accurate positioning, so as to improve the inkjet printing quality.

Method for printing on elevation contours of the print object

The present invention provides an inkjet printing method using an inkjet printing apparatus, the method including: Control the print heads in the first row of the first group on carriage to print the first color printing image on the transparent media. Control the first nozzle section on print heads in the second row of the second group on carriage to print the first white ink layer on the first color printing image. Control the second nozzle section on black ink print head in the second row of the first group on carriage to jet black ink to form coating layer on the first white ink layer. Control the third nozzle section on print heads in the second row of the second group on carriage to print the second white ink layer on the said coating layer. Control the print heads in the third row of the first group on carriage print the second color printing image on the second white ink layer. The print heads are arranged in three rows in this invention. The print heads in the second row are divided into three nozzle sections. With a single direction transport of the transparent media rather than back and forth transport, double sides images can be formed through five layers printing on the transparent media by controlling three nozzle sections on black and white ink print head in the second row.

Inkjet printing method and inkjet printing apparatus

The present invention relates to an inkjet printing apparatus, includes at least four same-typed print heads, among which, at least two eject ink for coating layer, the rest for colored inks; print heads printing coating layer are interpolated or arranged abreast in a row, and those for colored inks are ranked abreast in another; along printing medium's motion direction, nozzles of print heads ejecting the same colored ink are connected in series. Arranging or interpolating print heads ejecting ink for coating layer in a row and print heads ejecting colored inks arranged abreast in another to make whole printing area covered by coating layer in the present invention, greatly narrow width of print head baseplate, reduce demands on width of UV solidification devices, save cost, and improve operating stability of carriage.

Inkjet printing apparatus and printing method

The present invention relates to a kind of inkjet printer's ink protection method including: the developer generates a rechargeable code in accordance with the print head's nPL, total ink volume Gand user's identifying information provided by the user; the user purchases ink and its corresponding rechargeable code, inputs the rechargeable code into the printer's control system, and fills ink cartridge in the ink supply system with ink; the printer's control system verifies the effectiveness of the rechargeable code; if the rechargeable code is effective, total ink volume Gwill be added into the ink counter; if not, the rechargeable code is output as ineffective. This ink protection method in the present invention can increase ink utilization rate, reduce the waste of resources and cost, protect the environment, avoid equipment breakdowns caused by using unqualified ink, and improve printer's operating stability. What's more the present ink protection method utilizes printer's software and hardware technologies in prior art, needs no extra equipment, and thus has strong practicability and is cost effective.

Inkjet printer's ink protection method

This invention provides an isolated peptide encoded by a nucleic acid which is at least 30 nucleotides in length and has a sequence which uniquely defines a herpesvirus associated with Kaposis' sarcoma, which herpesvirus is present in and recoverable from the HBL-6 cell line (ATCC Accession No. CRL 11762).

Unique associated kaposi's sarcoma virus sequences and uses thereof

This invention provides an isolated nucleic acid which encodes a Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 polypeptide (LANA2) or a fragment thereof and also provides the LANA2 polypeptide. This invention provides an isolated nucleic acid comprising consecutive nucleotides having the sequence of a promoter of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 transcription. This invention also provides a method of inhibiting p53 mediated apoptosis of a cell and a method of producing an antibody which comprises introducing into a cell a replicable vector of the subject invention.

Spliced gene of KSHV/HHV8, its promoter and monoclonal antibodies specific for LANA2

Spliced gene of KSHV / HHV8, its promoter and monoclonal antibodies specific for LANA2

The present invention relates to an immunogenic determinant. More particularly, it relates to a protein or a protein fragment for use in the diagnosis of Kaposi's sarcoma or human herpesvirus 8 (KSHV/HHV8) and to a diagnostic kit utilising the protein or protein fragment of the invention. The amino acid sequence of the carboxyterminal end of KSHV orf 65 is given below: Sequence 1: Amino acids 86-170 of KSHV orf 65. ADRVSAASY DAGTFTVPSR PGPASGTTPG GQDSLGVSGS SITTLSSGPH SLSPASDILT TLSSTTETTA PAVADARKPP SGKKK.

Immunogenic determinant for use in the diagnosis of Kaposi's sarcoma

This invention provides an isolated DNA molecule which is at least 30 nucleotides in length and which uniquely defines a herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated peptide encoded by the isolated DNA molecule. Further, this invention provides an isolated DNA virus wherein the viral DNA is about 270 kb in size; wherein the DNA encodes a thymidine kinase; and wherein the viral DNA is capable of selectively hybridizing to a nucleic acid probe selected from the group consisting of SEQ. ID NOs:10-12. This invention provides an antibody specific to the peptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a transgenic nonhuman mammal and a cell line containing at least a portion of the isolated DNA molecule. This invention provides a method of vaccinating a subject for KS, prophylaxis diagnosing or treating a subject with KS and detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.

Unique associated Kaposi's sarcoma virus sequences and uses thereof

This invention provides an isolated nucleic acid molecule which encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) polypeptides. This invention provides an isolated polypeptide molecule of KSHV. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine for Kaposi's Sarcoma (KS). This invention provides methods of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and of detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.

Unique associated Kaposi's Sarcoma virus sequences and uses thereof

This invention provides an isolated DNA molecule which is at least 30 nucleotides in length and which uniquely defines a herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated peptide encoded by the isolated DNA molecule. Further, this invention provides an isolated DNA virus wherein the viral DNA is about 270 kb in size; wherein the DNA encodes a thymidine kinase; and wherein the viral DNA is capable of selectively hybridizing to a nucleic acid probe selected from the group consisting of SEQ. ID NOs: 10-12. This invention provides an antibody specific to the peptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a transgenic nonhuman mammal and a cell line containing at least a portion of the isolated DNA molecule. This invention provides a method of vaccinating a subject for KS, prophylaxis diagnosing or treating a subject with KS and detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.

This invention provides an isolated nucleic acid molecule which encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) immediate early protein (IEP). This invention provides an isolated polypeptide molecule which encodes KSHV immediate early protein. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine for Kaposi's Sarcoma (KS). This invention provides methods of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and of detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.

Growing community of inventors

New York, NY, United States of America

Yuan Chang